FdaApplication
ANDA 062117
Identifiers
- fda_app_no: ANDA062117
Properties
| Property | Value |
|---|---|
| applicant_name | FACTA FARMACEUTICI SPA |
| application_type | ANDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEPHALEXIN | CEPHALEXIN | EQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons* | FOR SUSPENSION;ORAL |
| CEPHALEXIN | CEPHALEXIN | EQ 125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons* | FOR SUSPENSION;ORAL |
| CEPHALEXIN | CEPHALEXIN | EQ 100MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons* | FOR SUSPENSION;ORAL |
3 products